CLINICAL AND MICROBIOLOGICAL ANALYSIS LABORATORY LIMITED
Executive Summary
Clinical and Microbiological Analysis Laboratory Limited possesses a solid financial foundation with significant fixed assets and positive net equity, indicating stability and good solvency. However, its relatively low current assets highlight a need to improve liquidity and cash flow management to ensure operational flexibility. With focused attention on working capital and profitability monitoring, the company can strengthen its financial wellness and support sustainable growth.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 31/05/2531 May 2025 | Micro company accounts made up to 2024-08-31 |
| 09/11/249 November 2024 | Compulsory strike-off action has been discontinued |
| 09/11/249 November 2024 | Compulsory strike-off action has been discontinued |
| 07/11/247 November 2024 | Confirmation statement made on 2024-08-03 with no updates |
| 22/10/2422 October 2024 | First Gazette notice for compulsory strike-off |
| 22/10/2422 October 2024 | First Gazette notice for compulsory strike-off |
| 31/08/2431 August 2024 | Annual accounts for year ending 31 Aug 2024 |
| 31/05/2431 May 2024 | Micro company accounts made up to 2023-08-31 |
| 31/08/2331 August 2023 | Annual accounts for year ending 31 Aug 2023 |
| 21/08/2321 August 2023 | Confirmation statement made on 2023-08-03 with no updates |
| 31/05/2331 May 2023 | Micro company accounts made up to 2022-08-31 |
| 04/05/224 May 2022 | Micro company accounts made up to 2021-08-31 |
| 31/08/2131 August 2021 | Annual accounts for year ending 31 Aug 2021 |
| 04/08/204 August 2020 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company